IP Library Granted Patent US 7,029,703
Granted Patent B2
US 7,029,703 · App. 10/241,616 · Granted Apr 18, 2006

Composition for promoting healthy bone structure

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,029,703
App. No.
10/241,616
Granted
Apr 18, 2006
Kind
B2
Abstract

A dietary supplement for benefitting human bone health includes a calcium source, a source of vitamin D activity, and an osteoblast stimulant. A preferred calcium source is microcrystalline hydroxyapatite, which also contains protein (mostly collagen), phosphorus, fat, and other minerals. A preferred source of vitamin D activity is cholecalciferol, and a preferred osteoblast stimulant is ipriflavone. In addition to these basic ingredients, the composition can further include various other minerals known to occur in bone, vitamin C, and glucosamine sulfate, all of which exert beneficial effects on growth and maintenance of healthy bone. A method for benefitting human bone health involves administering a daily regimen of the dietary supplement.

Claims (24)

1. A composition for benefiting human bone health, comprising an effective amount of a calcium source; an effective amount of a source of vitamin D activity comprising cholecalciferol present in the range from about 50 IU to about 300 IU; and an effective amount of ipriflavone.

2. The composition of claim 1 , wherein th calcium source comprises microcrystalline hydroxyapatite.

3. The composition of claim 1 , wherein ipriflavone is in dry emulsion form.

4. The composition of claim 1 , wherein ipriflavone is present in the range from about 100 mg to about 600 mg.

5. The composition of claim 1 , further comprising an ingredient selected from the group consisting of a magnesium source, a silicon ingredient, a boron ingredient, and glucosamine sulfate.

6. The composition of claim 1 , further comprising magnesium.

7. The composition of claim 6 , wherein the magnesium is in the form of magnesium citrate.

8. The composition of claim 6 , wherein the magnesium is in the form of magnesium oxide.

9. The composition of claim 7 , wherein the magnesium is in the form of magnesium citrate and magnesium oxide.

10. The composition of claim 1 , further comprising boron.

11. The composition of claim 10 , wherein the boron is in the form of boron citrate.

12. The composition of claim 1 , further comprising an ingredient selected from the group consisting of a copper ingredient, a zinc ingredient, a manganese ingredient, a chromium ingredient, and a vitamin C ingredient.

13. A method for supplementing a diet for benefiting human bone health comprising administering at least one daily serving of a composition comprising: an effective amount of a calcium source; an effective amount of source of vitamin D activity comprising cholecalciferol present in the range from about 50 IU to about 300 IU; and an effective amount of ipriflavone.

14. The method of claim 13 , wherein the calcium source comprises microcrystalline hydroxyapatite.

15. The method of claim 13 , wherein the ipriflavone is in dry emulsion form.

16. The method of claim 13 , wherein the ipriflavone is present in the range from about 100 mg to about 600 mg.

17. The method of claim 13 , further comprising an ingredient selected from the group consisting of a magnesium source, a silicon ingredient, a boron ingredient, and glucosamine sulfate.

18. The method of claim 13 , further comprising magnesium.

19. The method of claim 18 , wherein the magnesium is in the form of magnesium citrate.

20. The method of claim 18 , wherein the magnesium is in the form of magnesium oxide.

21. The method of claim 18 , wherein the magnesium is in the from of magnesium citrate and magnesium oxide.

22. The method of claim 13 , further comprising boron.

23. The method of claim 22 , wherein the boron is in the form of boron citrate.

24. The method of claim 13 , further comprising an ingredient selected from the group consisting of a copper ingredient, a zinc ingredient, a manganese ingredient, a chromium ingredient, and a vitamin C ingredient.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Oct 25, 2021
From: BANK OF AMERICA, N.A.
To: METAGENICS, INC.
Reel/Frame 057909/0315 →
RELEASE OF SECURITY INTEREST Recorded Oct 26, 2009
From: COMERICA BANK
To: METAGENICS, INC.; METAGENICS FAR EAST, INC.; META PROTEOMICS, LLC
Reel/Frame 023419/0662 →
SECURITY AGREEMENT Recorded Oct 15, 2009
From: METAGENICS, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 023373/0771 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 6, 2008
From: KRUMHAR, KIM C.; JOHNSON, HOLLY A.
To: METAGENICS, INC.
Reel/Frame 021795/0306 →
SECURITY AGREEMENT Recorded Jun 2, 2006
From: METAGENICS, INC.; METAGENICS FAR EAST, INC.; META PROTEOMICS, L.L.C.
To: COMERICA BANK
Reel/Frame 017706/0815 →